2024 Spain Hospital Hematology and Flow Cytometry Markets: Supplier Shares, Sales Segment Forecasts and Strategic Profiles of Leading Competitors

2024 Spain Hospital Hematology and Flow Cytometry Markets: Supplier Shares, Sales Segment Forecasts and Strategic Profiles of Leading Competitors

  • September 2020 •
  • 236 pages •
  • Report ID: 5841271 •
  • Format: PDF
2024 Spain Hospital Hematology and Flow Cytometry Markets: Supplier Shares, Sales Segment Forecasts and Strategic Profiles of Leading Competitors

This new report contains 236 pages and 15 tables.

The report is available by section, and can be customized to specific information needs and budget.

The report presents a comprehensive analysis of the Spanish hospital hematology and flow cytometry markets, including: 

  • Major issues pertaining to the Spanish hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. 
  • Five-year volume and sales forecasts for major hematology and flow cytometry tests performed in Spanish hospitals. 
  • Annual placements and installed base estimates for major automated and semiautomated hematology analyzers and flow cytometers.  
  • Review of current instrumentation technologies, and a feature comparison
    of high-, medium-, and low-volume/POC analyzers. 
  • Five-year reagent and instrument sales forecasts. 
  • Sales and market shares of leading reagent and instrument suppliers. 
  • Review of current and emerging technologies, and their potential market applications. 
  • Product development opportunities for instruments, consumables, and auxiliary products. 
  • Profiles of major current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in RandD, collaborative arrangements, and business strategies. 
  • Business opportunities and strategic recommendations for suppliers.

    Contains 236 pages and 15 tables



    Companies Profiled

    Competitive Assessments

    - Abbott
    - Agilent Technologies
    - Beckman Coulter/Danaher
    - Becton Dickinson
    - Bio-Rad
    - CellaVision
    - Horiba
    - Nihon Kohden
    - Ortho-Clinical Diagnostics
    - Roche
    - Siemens Healthineers
    - Sysmex